PODCASTS

Intro

Welcome to the NASH: Take Action! podcast, a CME program brought to you by the American Gastroenterological Association. This six-episode podcast series is hosted by Drs. Fasiha Kanwal, Kenneth Cusi and Jay H. Shubrook.

The series is ACCME accredited and sponsored by an independent medical education grant from Novo Nordisk.

You can find all six episodes here or on your favorite podcast app.

Click through to a podcast to learn more about how to collect CME credit for each one.

This activity is accredited through Sep. 30, 2022.

Episodes

Episode 1: The Burden of Nash

Episode 1: The Burden of Nash

Global leaders in gastroenterology, hepatology, endocrinology and primary care talk about the real-world, practical implications of screening, diagnosing and managing people with NAFLD and NASH.
Listen NOW
Episode 2: NASH and Metabolic Syndrome

Episode 2: NASH and Metabolic Syndrome

We talk to Lee Kaplan, MD, founding director of the Weight Center at Massachusetts General Hospital, about the relationship between NASH, obesity and associated comorbidities.
Listen NOW
Episode 3: Screening for NAFLD and NASH

Episode 3: Screening for NAFLD and NASH

We talk to Kim Pfotenhauer, DO, Michigan State University and Eugene Wright, MD, Duke University about screening people for NAFLD in the primary care setting.
Listen NOW
Episode 4: Diagnosing NAFLD and NASH

Episode 4: Diagnosing NAFLD and NASH

We talk to Vincent Wong, MD, The Chinese University of Hong Kong, about noninvasive diagnostic techniques for patients at high risk for NASH and the role of liver biopsy in diagnosing NASH.
Listen NOW
Episode 5: Managing NAFLD and NASH

Episode 5: Managing NAFLD and NASH

We talk to Robert H. Eckel, MD, University of Colorado, about limitations in current data about managing NAFLD and NASH and emerging therapies.
Listen NOW
Episode 6: Working Together

Episode 6: Working Together

We talk to Hashem El-Serag, MD, Baylor College of Medicine, about collaboration between primary care providers and specialists in managing patients with NAFLD and NASH.
Listen NOW